Yuichiro Shindo

11PUBLICATIONS
46CO-AUTHORS
Patient safetyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 27, 2026
Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.

|Jul 30, 2025
Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Toshihiro Kita, Norio Ohmagari, Sho Saito

|Mar 28, 2025
Influence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan.

Kosaku Komiya, Akihiko Hagiwara, Yuichiro Shindo

|Nov 27, 2024
Impact of Education on Inappropriate Antibiotic Prescription for Respiratory Tract Infection Based on Physicians' Justifications: A Web-Based Survey in Japan.

Ryohei Kudoh, Kosaku Komiya, Norihito Kaku

|Aug 09, 2021
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure.

Yuichiro Shindo, Yasuhiro Kondoh, Akiko Kada

|Jul 09, 2021
Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report.

Charles S Dela Cruz, Scott E Evans, Marcos I Restrepo

Pageof 2

Frequent Collaborators

3 joint publications

Kosaku Komiya

2 joint publications

Keisuke Tomii

2 joint publications

Takahiro Takazono

1 joint publications

Mark Berry